Moschetta, Antonio

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism

Drug Transport and Resistance MechanismsFibroblast Growth Factor Research

Cited by 1,865

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences

Drug Transport and Resistance MechanismsGut microbiota and health

Cited by 1,164

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 870

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery

Fibroblast Growth Factor ResearchParathyroid Disorders and Treatments

Cited by 424

Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice

Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., & Moschetta, A. (2014) · Cell Reports

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 356

Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis

Modica, S., Petruzzelli, M., Bellafante, E., Murzilli, S., Salvatore, L., Celli, N., Di Tullio, G., Palasciano, G., Moustafa, T., Halilbasic, E., et al. (2012) · Gastroenterology

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 275

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes

Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023) · eBioMedicine

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 251

Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation

Degirolamo, C., Modica, S., Vacca, M., Di Tullio, G., Morgano, A., D'Orazio, A., Kannisto, K., Parini, P., & Moschetta, A. (2015) · Hepatology

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 121

Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil

D'Amore, S., Vacca, M., Cariello, M., Graziano, G., D'Orazio, A., Salvia, R., Sasso, R. C., Sabbà, C., Palasciano, G., & Moschetta, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Edible Oils Quality and AnalysisFatty Acid Research and Health

Cited by 107

Severe impairment of postprandial cholecystokinin release and gall‐bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR

Moschetta, A., Stolk, M. F. J., Rehfeld, J. F., Portincasa, P., Slee, P. H. T. J., Koppeschaar, H. P. F., Van Erpecum, K. J., & Vanberge‐Henegouwen, G. P. (2001) · Alimentary Pharmacology & Therapeutics

Pituitary Gland Disorders and TreatmentsGallbladder and Bile Duct Disorders

Cited by 79

Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts

Petruzzelli, M., Vacca, M., Moschetta, A., Cinzia Sasso, R., Palasciano, G., van Erpecum, K. J., & Portincasa, P. (2007) · Clinical Biochemistry

Inflammatory mediators and NSAID effectsDrug-Induced Hepatotoxicity and Protection

Cited by 46

Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study

Vozza, A., Triggiani, D., Fanelli, M., Lisco, G., Coletto, D., Custodero, C., Volpe, S., Racaniello, D., Colaianni, V., Lavarra, V., et al. (2025) · Frontiers in Endocrinology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 12